| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2002-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699420fdfdca00412adc7cb376fe4c58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a9823cdad566690f3b94f118850bbbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_012194dcb947ec4d3324a74b713a8b42 |
| publicationDate |
2003-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003105329-A1 |
| titleOfInvention |
Process for the production of piperidine derivatives |
| abstract |
The present invention relates to processes for preparing certain piperidine derivatives, including fexofenadine (F), the active ingredient in the non-sedating antihistamine sold in the U.S. under the designation “Allegra®”. This invention also relates to novel synthetic intermediates useful in the processes of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10696633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008012859-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008012859-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011190504-A1 |
| priorityDate |
2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |